Experimental Study of Effect of Paclitaxel Combined with Cisplatin on Cervical Carcinoma Cell Line HCE1 Cell
Xin Peng
2012-01-01
Abstract:Objective To study cervical carcinoma cell line HCE1 cell in the therapy of chemotherapy regimen of paclitaxel combined with cisplatin treated on.Methods(1)The human cervical carcinoma cell line HCE1 cells were cultured.(2)Essay grouping and measure:HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentrations for 24 h respectively.Cell viability were measured by MTT assay.At the same time,HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentration for 24,48 and 72 h,by cisplatin with 20 μg/ml,40 μg/ml and 80 μg/ml concentration for 24,48 and 72 h,by paelitaxel combined with cisplatin for 24,48 and 72 h,the effect of paelitaxel on HCE1 cells were analyzed by MTT assay,respectively.HCE1 cells were cultured and treated by paelitaxel with 20 μmol/L,40 μmol/L and 80 μmol/L concentrations for 24,48,72 h,the apoptotic rate of HCE1 cell were analyzed by flow cytometry after PI staining,respectively.Treated with 20 μmol/L,40 μmol/L and 80 μmol/L paelitaxel,20 μg/ml,40 μg/ml and 80 μg/ml cisplatin,paelitaxel combined with cisplatin for 24,48 and 72 h,the apoptotic rate and cell cycle distribution were analyzed by flow cytometry after PI staining,respectively.Results(1)HCE1cells became round,small,cell shrinkage,membrane blebbing and so on,after exposed to paelitaxel.(2)After treated with paelitaxel with concentration about 20 μmol/L,40 μmol/L,80 μmol/L for 24 h,HCE1 cell inhibition rate discern was(9.5±0.66)%,(17.1±1.51)%,(33.3±1.77)%,after 48 h,HCE1 cell inhibition rate discern was(28.0±2.27)%,(45.2±3.15)%,(66.0±2.95)%,after 72 h,HCE1 cell inhibition rate discern was(39.4±2.81)%,(66.2±7.02)%,(81.5±1.78)%.After treated with cisplatin with concentration about 20 μg/ml,40 μg/ml and 80 μg/ml for 24 h,HCE1 cell inhibition rate discern was(3.6±0.56)%,(6.5±0.98)%,(14.1±2.52)%,after 48 h,HCE1 cell inhibition rate discern was(6.5±0.46)%,(9.9±1.35)%,(20.0±3.05)%,after 72 h,HCE1 cell inhibition rate discern was(14.1±3.05)%,(42.1±3.90)%,(59.4±4.26)%.After treated with 20 μmol/L paelitaxel combined with 20 μg/ml cisplatin,HCE1 cell inhibition rate discern was(30.2±3.34)%,MTT assays showed that paelitaxel inhibited the growth of the cervical carcinoma cells by concentration and time dependent,and synergistic effect appeared when combined with cisplatin.(3)Flow cytometry results demonstrated that the cell cycle was redistributed:the G1-Phase cell fraction was conspicuous increased while the S-Phase cell fraction was significantly decreased after the cells were treated with paelitaxel(P0.05).However,the result was opposite after treated with cisplatin.When treated with both of them,G1-Phase and S-Phase cell fraction were between the values of single agent.For example,after treated with 20 μmol/L paelitaxel for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(86.0±3.01)% and(9.1±0.66)%,after treated with 40 μg/ml cisplatin for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(2.1±0.26)% and(92.2±6.24)%,after treated with 20 μmol/L paelitaxel combine with 40 μg/ml cisplatin for 48 h,the G1-Phase cell fraction and the S-Phase cell fraction were(13.2±0.78)% and(80.5±2.46)%.(4)Both of paelitaxel and cisplatin could induce apoptosis in cervical carcinoma cells by a time and dose dependent way.The apoptotic index were significantly increased after treated with paelitaxel combined with cisplatin.Conclusions The apoptotic index is significantly increased after treated with paelitaxel combined with cisplatin,suggesting that the combination of them could exert synergistic antiproliferative effect on cervical carcinoma cells.